Project

BIOLOPTIM: implementation of therapeutic drug monitoring for biologicals in psoriasis and hidradenitis supparativa

Acronym
BIOLOPTIM
Code
3179Q0118
Duration
01 October 2018 → 30 September 2022
Funding
Research Foundation - Flanders (FWO)
Promotor
Research disciplines
  • Medical and health sciences
    • Laboratory medicine
    • Palliative care and end-of-life care
    • Regenerative medicine
    • Other basic sciences
    • Laboratory medicine
    • Palliative care and end-of-life care
    • Regenerative medicine
    • Other clinical sciences
    • Other health sciences
    • Nursing
    • Other paramedical sciences
    • Laboratory medicine
    • Palliative care and end-of-life care
    • Regenerative medicine
    • Other translational sciences
    • Other medical and health sciences
Keywords
psoriasis hidradentitis supparativa
 
Project description
No data available